These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1989176)
1. Histocompatibility and other rejection risk factors in cardiac transplantation. Zerbe TR; Kormos R; Arena V; Griffith B; Hardesty R; Duquesnoy R Transplant Proc; 1991 Feb; 23(1 Pt 2):1155-6. PubMed ID: 1989176 [No Abstract] [Full Text] [Related]
2. Use of flow cytometric crossmatching in cardiac transplantation. Shenton BK; Glenville BE; Mitcheson AE; Coates E; Talbot D; Givan AL; Kirk A; Dark JH Transplant Proc; 1991 Feb; 23(1 Pt 2):1153-4. PubMed ID: 1989175 [No Abstract] [Full Text] [Related]
3. HLA antigen mismatching and HLA-specific antibodies in heart transplantation: review of a single center experience. The Manchester Wythenshawe Heart Transplant Team. Sheldon S; Dyer PA Transplant Proc; 1992 Dec; 24(6):2438. PubMed ID: 1465821 [No Abstract] [Full Text] [Related]
4. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function. Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758 [TBL] [Abstract][Full Text] [Related]
5. Influence of HLA matching on graft survival and incidence and severity of graft rejection in cardiac transplantation. Suberbielle C; Dorent R; Vaissier E; Nataf P; Busson M; Cabrol A; Cabrol C; Charron D; Raffoux C; Gandjbakhch I Transplant Proc; 1994 Feb; 26(1):245-6. PubMed ID: 8108959 [No Abstract] [Full Text] [Related]
6. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients. George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720 [TBL] [Abstract][Full Text] [Related]
7. Importance of donor-reactive cytotoxic antibodies following cardiac transplantation. Smith JD; Morgan AJ; Bravery C; Rose ML; Sachs JA; Yacoub MH Transplant Proc; 1991 Feb; 23(1 Pt 2):1133-4. PubMed ID: 1989168 [No Abstract] [Full Text] [Related]
13. Early and late rejection and HLA sensitization at the time of heart transplantation in patients bridged with left ventricular assist devices. Gonzalez-Stawinski GV; Atik FA; McCarthy PM; Roselli EE; Hoercher K; Navia JL; Smedira NG; Starling RC; Young JB; Cook DJ Transplant Proc; 2005 Mar; 37(2):1349-51. PubMed ID: 15848717 [TBL] [Abstract][Full Text] [Related]
14. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302 [TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated rejection without acute graft dysfunction in adult ABO-compatible heart transplantation: a case of accommodation. Angelini A; Castellani C; Poli F; Benazzi E; Torregrossa G; Tona F; Gambino A; Caforio AP; Feltrin G; Toscano G; Valente M; Thiene G; Gerosa G J Heart Lung Transplant; 2008 Dec; 27(12):1357-60. PubMed ID: 19059119 [TBL] [Abstract][Full Text] [Related]
16. Immunology of pediatric heart transplantation: a clinical update. Webber SA Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2001; 4():158-84. PubMed ID: 11460982 [TBL] [Abstract][Full Text] [Related]
17. The clinical relevance of HLA matching in heart transplantation: impact on rejection and donor-directed cytotoxicity of graft infiltrating lymphocytes. Baan CC; Ouwehand AJ; Vaessen LM; Jutte NH; Balk AH; Mochtar B; Claas FH; Weimar W Transplant Proc; 1991 Oct; 23(5):2670-1. PubMed ID: 1926527 [No Abstract] [Full Text] [Related]